These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9248638)

  • 21. In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial.
    Ng KF; Lam CC; Chan LC
    Br J Anaesth; 2002 Apr; 88(4):475-80. PubMed ID: 12066721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antithrombin III in the treatment of disseminated intravascular coagulation].
    Nordgaard-Andersen I; Madsen JR
    Ugeskr Laeger; 1997 Feb; 159(6):730-1. PubMed ID: 9045459
    [No Abstract]   [Full Text] [Related]  

  • 23. Antithrombin III in Sepsis. New evidences and open questions.
    Ostermann H
    Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel model of burn-blast combined injury and its phasic changes of blood coagulation in rats.
    Chai JK; Liu W; Deng HP; Cai JH; Hu QG; Zou XF; Shen CA; Yin HN; Han YF; Zhang XB; Chi YF; Ma L; Sun TJ; Feng R; Lan YT
    Shock; 2013 Oct; 40(4):297-302. PubMed ID: 23364430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation.
    Ruttmann TG; James MF; Aronson I
    Br J Anaesth; 1998 May; 80(5):612-6. PubMed ID: 9691864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombin-III substitution in preterm infants--effect on intracranial hemorrhage and coagulation parameters.
    Brangenberg R; Bodensohn M; Bürger U
    Biol Neonate; 1997; 72(2):76-83. PubMed ID: 9267673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombin III concentrate in the acute phase of thermal injury.
    Kowal-Vern A; McGill V; Walenga JM; Gamelli RL
    Burns; 2000 Feb; 26(1):97-101. PubMed ID: 10630326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III.
    Uchiba M; Okajima K
    Semin Thromb Hemost; 1997; 23(6):583-90. PubMed ID: 9469634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epilogue: disseminated intravascular coagulation and antithrombin III in intensive care medicine: pathophysiological insights and therapeutic hopes.
    Schuster HP
    Semin Thromb Hemost; 1998; 24(1):81-3. PubMed ID: 9515783
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
    Cohendy R; Lefrant JY; de la Coussaye JE
    Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
    [No Abstract]   [Full Text] [Related]  

  • 31. Current drug treatment strategies for disseminated intravascular coagulation.
    de Jonge E; Levi M; Stoutenbeek CP; van Deventer SJ
    Drugs; 1998 Jun; 55(6):767-77. PubMed ID: 9617592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antithrombin III substitution in patients in shock].
    Vinazzer H; Blauhut B; Bergmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of blood coagulation and fibrinolysis during and after hydroxyethyl starch (HES) colloidal volume replacement.
    Omar MN; Shouk TA; Khaleq MA
    Clin Biochem; 1999 Jun; 32(4):269-74. PubMed ID: 10463819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
    Kanbak M
    Can J Anaesth; 1999 Jun; 46(6):581-5. PubMed ID: 10391608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Purpura fulminans in the newborn. Report of two cases successfully treated with heparin and antithrombin III].
    Ficuccilli F; Iacobini M; Beglieri MR; Papoff P; Mancuso M; Caradonna A; Donato AI; Colarizi P
    Minerva Pediatr; 1997 Dec; 49(12):571-7. PubMed ID: 9577159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of coagulation and fibrinolysis in hepatic resection: a randomized prospective control study using antithrombin III concentrates.
    Shimada M; Matsumata T; Kamakura T; Hayashi H; Urata K; Sugimachi K
    Thromb Res; 1994 Apr; 74(2):105-14. PubMed ID: 8029811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage II breast cancer patients.
    Pectasides D; Tsavdaridis D; Aggouridaki C; Tsavdaridou V; Visvikis A; Tsatalas K; Fountzilas G
    Anticancer Res; 1999; 19(4C):3521-6. PubMed ID: 10629646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation inhibitor substitution during sepsis.
    Fourrier F; Jourdain M; Tournois A; Caron C; Goudemand J; Chopin C
    Intensive Care Med; 1995 Nov; 21 Suppl 2():S264-8. PubMed ID: 8636534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of antithrombin administration in the acute phase of burn injury.
    Lavrentieva A; Kontakiotis T; Bitzani M; Parlapani A; Thomareis O; Scourtis H; Tsotsolis N; Lazaridis L; Giala MA
    Thromb Haemost; 2008 Aug; 100(2):286-90. PubMed ID: 18690349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.